Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation by D. Barouch, P.-T. Liu, B. Keele, P. Abbink, N. Mercado, R. Geleziunas

Connect to this object online.

Delay in viral rebound with TLR7 agonist, N6-LS and PGT121 in SHIV-infected macaques by D. Hsu, D. Silsorn, R. Imerbsin, A. Pegu, J. Mascola, R. Geleziunas, R. Koup, D. Barouch, N. Michael, S. Vasan

Connect to this object online.

OP 8.4 - 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption by H. King, D. Brammer, C. Lehman, M. Roederer, D. Bolton, R. Mason, K. Song, K. Foulds, J. Lifson, P. Darrah, R. Geleziunas

Connect to this object online.

Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals by S. Riddler, M. Para, C. Benson, A. Mills, M. Ramgopal, E. Dejesus, C. Brinson, J. Cyktor, J. Mellors, S. Guo, B. Doehle, S. Markova, H. Patel, H. Graham, J. Hesselgesser, R. Geleziunas, D. Brainard, S. McCallister, D. Sengupta

Connect to this object online.

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques by M. Mavigner, C. Deleage, J. Habib, E. Rosen, A. Kashuba, F. Amblard, R. Schinazi, R. Geleziunas, J. Hesselgesser, B. Li, J. Hattersley, C. McGary, M. Paiardini, M. Wood, D. Sodora, G. Silvestri, J. Estes, A. Chahroudi

Connect to this object online.